EsoCap is developing a novel smart drug delivery technology enabling targeted and long-lasting local therapy of the esophagus for the first time. Our business model is to demonstrate the clinical feasibility in one indication, (EoE), and to enter into a transaction with a major partner.
Facts & figures
-
Type of organizationPrivate company
-
Year of foundation2017
-
Number of employees in Switzerland1-9